Strategic Insight
Strategic Toolbox
We begin every strategic project by developing a clinical and competitive landscape. Publically available information is collected and organized in a clear, concise package. Our two most comprehensive products, the Oncology Compass and Standard of Care Reference Guide, both summarize the key clinical trials that led to the evolution of the current standard of care. In addition, the Oncology Compass provides competitive insight that has the potential to impact clinical treatment patterns. Our Science Team attends the major worldwide conferences to keep up-to-date on cutting edge clinical data and shifts in treatment paradigm. The customizable DAVA Toolbox provides the foundation for any successful consulting project.
Compass
The ongoing shift from segmentation by tumor histology towards molecularly defined subsets exemplifies a recent and important trend in oncology drug development. The complex molecular pathways that drive tumor growth, each with multiple drug-able targets, provide a challenge for the clinical development of pipeline assets and portfolio planning.
The Compass is an easy-to-navigate repository of key clinical and competitive data. The Compass is designed to support cross-functional teams involved in strategic planning and decision making related to clinical development and/or the life cycle management of portfolio assets.
Reference Guide
Tumor-specific Reference Guides provide a historical perspective by capturing the dynamics of the ever-changing standard of care in oncology. Relevant data is highlighted from selected key studies that have been instrumental in evolving practice patterns. Reference Guides also provide the objective impact and authors’ conclusions. The Reference Guide format is user friendly and easy-to-navigate by any audience; the final format is a clickable PDF which can be used on a PC, iPad, or company web-portal.
Clinical and Competitive Landscape
DAVA's inclusive landscape analysis provides the knowledge to gain an advantage over your competition's marketability. To create the Clinical Landscape, we focus on the current and future treatment paradigms, clinical and molecular patient segmentation, epidemiology, tumor biology, and role of biomarkers. The competitive analyses highlight regulatory strategies and developmental timelines of critical competitors in the tumor space.
Pathway Navigator
Cellular and molecular pathway targets are a current focus of many drug development strategies. The Pathway Navigator builds on a Clinical and Competitive Landscape platform, but provides a deeper analysis of the mechanism of action and strategies of competitors across multiple tumor types.
Congress Coverage
This process begins with a pre-meeting benchmark analysis and congress road map of relevant data being presented. The comprehensive congress coverage includes post-meeting analysis, commentary, and insight by DAVA's medical oncology experts.
